Top News

Pfizer to Acquire Seagen in $43 Billion Blockbuster Deal

March 16, 2023

Pfizer will acquire all outstanding shares of Seagen for a total of $43 billion.

Sumitovant Acquires Myovant for $1.7 Billion

March 14, 2023

Sumitovant Bipharma has completed its acquisition of Myovant Sciences for approximately $1.7 billion.

Biotech Companies Deal with Silicon Valley Bank Collapse

March 13, 2023

Silicon Valley Bank has collapsed, leaving many biotechnology companies unsure of the future.

Eli Lilly to Cap Out-Of-Pocket Insulin Costs at $35

March 02, 2023

Lilly will cap insulin prices for patients with and without insurance at $35 per month.

Investigational Personalized mRNA Cancer Vaccine Gains Breakthrough Therapy Designation from FDA

February 28, 2023

Moderna and Merck’s investigational personalized mRNA cancer vaccine has been granted Breakthrough Therapy Designation by FDA.

Pfizer Announces Positive Data for Prostate Cancer Combination Treatment

February 22, 2023

Pfizer reports that the combination of talazoparib and enzalutamide demonstrated statistically significant improvement in patient survival in a Phase III trial.

Astellas to Appoint New CEO and President

February 07, 2023

Naoki Okamura, Astellas’ current chief strategy officer, will take over the role from Kenji Yasukawa.

AstraZeneca Inks $1.8 Billion Acquisition for CinCor Pharma

January 11, 2023

The definitive agreement will give AstraZeneca global rights to CinCor’s portfolio of cardiorenal disease treatments.

Chiesi Acquires Rare Diseases Company in $1.47 Billion Deal

January 11, 2023

Chiesi will acquire Amryt Pharma, a commercial-stage biopharmaceutical company, in a deal worth up to $1.47 billion.

Ipsen to Bolster Liver Disease Portfolio with Albireo Acquisition

January 11, 2023

Ipsen’s $952 million acquisition of Albireo is designed to bolster the company's rare disease portfolio.